» Articles » PMID: 27143854

Possible Association Between Acetazolamide Administration During Pregnancy and Multiple Congenital Malformations

Overview
Specialty Pharmacology
Date 2016 May 5
PMID 27143854
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital malformations might occur because of environmental or genetic factors, and sometimes occur because of unknown causes. Acetazolamide is a carbonic anhydrase inhibitor that is used to treat idiopathic intracranial hypertension, glaucoma, and epilepsy. The use of acetazolamide has not been recommended for pregnant women because of reported teratogenic risks. Congenital malformations, such as ectrodactyly, syndactyly, cleft lip/palate, and retarded incisor teeth development, have been reported in experimental animals. However, tooth agenesis due to the use of acetazolamide has not been reported yet. Oligodontia is a severe type of tooth agenesis involving six or more congenitally missing teeth. The causes of oligodontia are attributed to environmental factors, such as irradiation, drugs, trauma, tumors, infection, genetic factors, or a combination. There is no credible evidence of undesirable effects of acetazolamide use in human pregnancy. However, we report a case of a 12-year-old Saudi boy who was exposed to maternal acetazolamide (1,000 mg/day) for treatment of idiopathic intracranial hypertension before pregnancy, during the first trimester, and throughout the pregnancy. This treatment might have resulted in some congenital malformations, such as ectrodactyly, syndactyly, and oligodontia.

Citing Articles

Advancing Glaucoma Treatment During Pregnancy and Breastfeeding: Contemporary Management Strategies and Prospective Therapeutic Developments.

Salvetat M, Toro M, Pellegrini F, Scollo P, Malaguarnera R, Musa M Biomedicines. 2025; 12(12.

PMID: 39767592 PMC: 11727364. DOI: 10.3390/biomedicines12122685.


Updating an Overview of Teratology.

Calado A, Seixas F, Pires M Methods Mol Biol. 2024; 2753:1-38.

PMID: 38285332 DOI: 10.1007/978-1-0716-3625-1_1.


Management and Outcome of Pregnancy in Patients With Idiopathic Intracranial Hypertension: A Prospective Case Series Study.

Vukovic-Cvetkovic V, Beier D, Buchgreitz L, Korsbaek J, Jensen R Neurol Clin Pract. 2024; 14(1):e200226.

PMID: 38213400 PMC: 10781565. DOI: 10.1212/CPJ.0000000000200226.


Acetazolamide: Old drug, new evidence?.

Shukralla A, Dolan E, Delanty N Epilepsia Open. 2022; 7(3):378-392.

PMID: 35673961 PMC: 9436286. DOI: 10.1002/epi4.12619.


Idiopathic Intracranial Hypertension: A Case Study of Patient Engagement in the Treatment of a Chronic Disease.

Gelkopf M, McAllister L, Gilani K, Sundaram A J Patient Exp. 2022; 9:23743735221094088.

PMID: 35465411 PMC: 9019380. DOI: 10.1177/23743735221094088.


References
1.
Wlodarczyk B, Palacios A, Chapa C, Zhu H, George T, Finnell R . Genetic basis of susceptibility to teratogen induced birth defects. Am J Med Genet C Semin Med Genet. 2011; 157C(3):215-26. DOI: 10.1002/ajmg.c.30314. View

2.
Celikoglu M, Kazanci F, Miloglu O, Oztek O, Kamak H, Ceylan I . Frequency and characteristics of tooth agenesis among an orthodontic patient population. Med Oral Patol Oral Cir Bucal. 2010; 15(5):e797-801. DOI: 10.4317/medoral.15.e797. View

3.
Falardeau J, Lobb B, Golden S, Maxfield S, Tanne E . The use of acetazolamide during pregnancy in intracranial hypertension patients. J Neuroophthalmol. 2012; 33(1):9-12. DOI: 10.1097/WNO.0b013e3182594001. View

4.
Jacobsen P, Henriksen T, Haubek D, Ostergaard J . Prenatal exposure to antiepileptic drugs and dental agenesis. PLoS One. 2014; 9(1):e84420. PMC: 3885552. DOI: 10.1371/journal.pone.0084420. View

5.
Basdra E, Kiokpasoglou M, Stellzig A . The Class II Division 2 craniofacial type is associated with numerous congenital tooth anomalies. Eur J Orthod. 2000; 22(5):529-35. DOI: 10.1093/ejo/22.5.529. View